Ca2+ channels and skeletal muscle diseases

Progress in Biophysics and Molecular Biology

Volumn 103, Issue 1, 2010, Pages 35-43

  Lee, Eun Hui ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM CHANNEL;

DRUG EFFECT; HOMEOSTASIS; HUMAN; METABOLISM; MUSCLE CONTRACTION; MUSCLE DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SKELETAL MUSCLE;

CALCIUM; CALCIUM CHANNELS; HOMEOSTASIS; HUMANS; MUSCLE CONTRACTION; MUSCLE, SKELETAL; MUSCULAR DISEASES;

EID: 77955272375     PISSN: 00796107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbiomolbio.2010.05.003     Document Type: Review

References (145)

1. Allen D.G., Whitehead N.P., Yeung E.W. Mechanisms of stretch-induced muscle damage in normal and dystrophic muscle: role of ionic changes. J. Physiol. 2005, 567:723-735.
2. Anderson A.A., Treves S., Biral D., Betto R., Sandona D., Ronjat M., Zorzato F. The novel skeletal muscle sarcoplasmic reticulum JP-45 protein. Molecular cloning, tissue distribution, developmental expression, and interaction with alpha 1.1 subunit of the voltage-gated calcium channel. J. Biol. Chem. 2003, 278:39987-39992.
3. 2+ channel Cav1.1. J. Cell Sci. 2006, 119:2145-2155.
4. 2+ channel. J. Gen. Physiol. 2000, 115:467-480.
5. 2+ entry. J. Gen. Physiol. 2009, 133:79-91.
6. Beurg M., Ahern C.A., Vallejo P., Conklin M.W., Powers P.A., Gregg R.G., Coronado R. Involvement of the carboxy-terminus region of the dihydropyridine receptor beta1a subunit in excitation-contraction coupling of skeletal muscle. Biophys. J. 1999, 77:2953-2967.
7. 2+-ATPase of sarcoplasmic reticulum. Expression in developing skeletal muscle. J. Biol. Chem. 1987, 262:3768-3774.
8. 2+ homeostasis is linked to increased muscle fatigability in the MG29 null mice. Cell Res. 2004, 14:373-378.
9. Cai C., Masumiya H., Weisleder N., Matsuda N., Nishi M., Hwang M., Ko J.K., Lin P., Thornton A., Zhao X., Pan Z., Komazaki S., Brotto M., Takeshima H., Ma J. MG53 nucleates assembly of cell membrane repair machinery. Nat. Cell Biol. 2009, 11:56-64.
10. Cai C., Masumiya H., Weisleder N., Pan Z., Nishi M., Komazaki S., Takeshima H., Ma J. MG53 regulates membrane budding and exocytosis in muscle cells. J. Biol. Chem. 2009, 284:3314-3322.
11. Cai C., Weisleder N., Ko J.K., Komazaki S., Sunada Y., Nishi M., Takeshima H., Ma J. Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin. J. Biol. Chem. 2009, 284:15894-15902.
12. Carafoli E., Garcia-Martin E., Guerini D. The plasma membrane calcium pump: recent developments and future perspectives. Experientia 1996, 52:1091-1100.
13. Chabrier S., Monnier N., Lunardi J. Early onset of hypokalaemic periodic paralysis caused by a novel mutation of the CACNA1S gene. J. Med. Genet. 2008, 45:686-688.
14. 2+ entry by depolarization of skeletal myotubes. Proc. Natl. Acad. Sci. U S A 2004, 101:15793-15798.
15. Cherednichenko G., Ward C.W., Feng W., Cabrales E., Michaelson L., Samso M., Lopez J.R., Allen P.D., Pessah I.N. Enhanced excitation-coupled calcium entry in myotubes expressing malignant hyperthermia mutation R163C is attenuated by dantrolene. Mol. Pharmacol. 2008, 73:1203-1212.
16. Conti A., Gorza L., Sorrentino V. Differential distribution of ryanodine receptor type 3 (RyR3) gene product in mammalian skeletal muscles. Biochem. J. 1996, 316(Pt 1):19-23.
17. Delbono O., Xia J., Treves S., Wang Z.M., Jimenez-Moreno R., Payne A.M., Messi M.L., Briguet A., Schaerer F., Nishi M., Takeshima H., Zorzato F. Loss of skeletal muscle strength by ablation of the sarcoplasmic reticulum protein JP45. Proc. Natl. Acad. Sci. U S A 2007, 104:20108-20113.
18. Dirksen R.T. Bi-directional coupling between dihydropyridine receptors and ryanodine receptors. Front. Biosci. 2002, 7:d659-d670.
19. + conduction and selectivity. Science 1998, 280:69-77.
20. Ducreux S., Zorzato F., Ferreiro A., Jungbluth H., Muntoni F., Monnier N., Muller C.R., Treves S. Functional properties of ryanodine receptors carrying three amino acid substitutions identified in patients affected by multi-minicore disease and central core disease, expressed in immortalized lymphocytes. Biochem. J. 2006, 395:259-266.
21. El-Hayek R., Ikemoto N. Identification of the minimum essential region in the II-III loop of the dihydropyridine receptor alpha 1 subunit required for activation of skeletal muscle-type excitation-contraction coupling. Biochemistry 1998, 37:7015-7020.
22. Engel A.G., Gomez M.R., Groover R.V. Multicore disease. A recently recognized congenital myopathy associated with multifocal degeneration of muscle fibers. Mayo Clin. Proc. 1971, 46:666-681.
23. Fontaine B., Vale-Santos J., Jurkat-Rott K., Reboul J., Plassart E., Rime C.S., Elbaz A., Heine R., Guimaraes J., Weissenbach J., et al. Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families. Nat. Genet. 1994, 6:267-272.
24. Formigli L., Sassoli C., Squecco R., Bini F., Martinesi M., Chellini F., Luciani G., Sbrana F., Zecchi-Orlandini S., Francini F., Meacci E. Regulation of transient receptor potential canonical channel 1 (TRPC1) by sphingosine 1-phosphate in C2C12 myoblasts and its relevance for a role of mechanotransduction in skeletal muscle differentiation. J. Cell Sci. 2009, 122:1322-1333.
25. Fouad G., Dalakas M., Servidei S., Mendell J.R., Van den Bergh P., Angelini C., Alderson K., Griggs R.C., Tawil R., Gregg R., Hogan K., Powers P.A., Weinberg N., Malonee W., Ptacek L.J. Genotype-phenotype correlations of DHP receptor alpha 1-subunit gene mutations causing hypokalemic periodic paralysis. Neuromuscul Disord. 1997, 7:33-38.
26. Fujiwara Y., Minor D.L. X-ray crystal structure of a TRPM assembly domain reveals an antiparallel four-stranded coiled-coil. J. Mol. Biol. 2008, 383:854-870.
27. Gailly P. New aspects of calcium signaling in skeletal muscle cells: implications in Duchenne muscular dystrophy. Biochim. Biophys. Acta 2002, 1600:38-44.
28. Giannini G., Conti A., Mammarella S., Scrobogna M., Sorrentino V. The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues. J. Cell Biol. 1995, 128:893-904.
29. Gillard E.F., Otsu K., Fujii J., Khanna V.K., de Leon S., Derdemezi J., Britt B.A., Duff C.L., Worton R.G., MacLennan D.H. A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. Genomics 1991, 11:751-755.
30. Grabner M., Dirksen R.T., Suda N., Beam K.G. The II-III loop of the skeletal muscle dihydropyridine receptor is responsible for the Bi-directional coupling with the ryanodine receptor. J. Biol. Chem. 1999, 274:21913-21919.
31. Gregg R.G., Messing A., Strube C., Beurg M., Moss R., Behan M., Sukhareva M., Haynes S., Powell J.A., Coronado R., Powers P.A. Absence of the beta subunit (cchb1) of the skeletal muscle dihydropyridine receptor alters expression of the alpha 1 subunit and eliminates excitation-contraction coupling. Proc. Natl. Acad. Sci. USA 1996, 93:13961-13966.
32. Guyton A.C., Hall J.E. Textbook of Medical Physiology 2006, Elsevier Saunders, Philadelphia, pp. xxxv, 1116.
33. Hakamata Y., Nakai J., Takeshima H., Imoto K. Primary structure and distribution of a novel ryanodine receptor/calcium release channel from rabbit brain. FEBS Lett. 1992, 312:229-235.
34. 2+ release from sarcoplasmic reticulum through silencing of junctophilin genes. Biophys. J. 2006, 90:4418-4427.
35. Hryshko L.V., Philipson K.D. Sodium-calcium exchange: recent advances. Basic Res. Cardiol. 1997, 92(Suppl. 1):45-51.
36. Huang G.N., Zeng W., Kim J.Y., Yuan J.P., Han L., Muallem S., Worley P.F. STIM1 carboxyl-terminus activates native SOC, I(crac) and TRPC1 channels. Nat. Cell Biol. 2006, 8:1003-1010.
37. Hurne A.M., O'Brien J.J., Wingrove D., Cherednichenko G., Allen P.D., Beam K.G., Pessah I.N. Ryanodine receptor type 1 (RyR1) mutations C4958S and C4961S reveal excitation-coupled calcium entry (ECCE) is independent of sarcoplasmic reticulum store depletion. J. Biol. Chem. 2005, 280:36994-37004.
38. 2+ transport as studied by reconstitution of cardiac sarcoplasmic reticulum. J. Biol. Chem. 1986, 261:1794-1800.
39. 2+-permeable growth factor-regulated channel. J. Cell Biol. 2003, 161:957-967.
40. Jin X., Touhey J., Gaudet R. Structure of the N-terminal ankyrin repeat domain of the TRPV2 ion channel. J. Biol. Chem. 2006, 281:25006-25010.
41. Jungbluth H., Zhou H., Sewry C.A., Robb S., Treves S., Bitoun M., Guicheney P., Buj-Bello A., Bonnemann C., Muntoni F. Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord. 2007, 17:338-345.
42. +-dependent paradoxical membrane depolarization and Na+ overload, major and reversible contributors to weakness by ion channel leaks. Proc. Natl. Acad. Sci. USA 2009, 106:4036-4041.
43. Ke T., Gomez C.R., Mateus H.E., Castano J.A., Wang Q.K. Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a South American family. J. Hum. Genet. 2009, 54:660-664.
44. Keating K.E., Quane K.A., Manning B.M., Lehane M., Hartung E., Censier K., Urwyler A., Klausnitzer M., Muller C.R., Heffron J.J., et al. Detection of a novel RYR1 mutation in four malignant hyperthermia pedigrees. Hum. Mol. Genet. 1994, 3:1855-1858.
45. Kimura Y., Inui M., Kadoma M., Kijima Y., Sasaki T., Tada M. Effects of monoclonal antibody against phospholamban on calcium pump ATPase of cardiac sarcoplasmic reticulum. J. Mol. Cell Cardiol. 1991, 23:1223-1230.
46. Kiselyov K., Mignery G.A., Zhu M.X., Muallem S. The N-terminal domain of the IP3 receptor gates store-operated hTrp3 channels. Mol. Cell 1999, 4:423-429.
47. Kiselyov K.I., Shin D.M., Wang Y., Pessah I.N., Allen P.D., Muallem S. Gating of store-operated channels by conformational coupling to ryanodine receptors. Mol. Cell 2000, 6:421-431.
48. Kruger J., Kunert-Keil C., Bisping F., Brinkmeier H. Transient receptor potential cation channels in normal and dystrophic mdx muscle. Neuromuscul Disord. 2008, 18:501-513.
49. Kugler G., Weiss R.G., Flucher B.E., Grabner M. Structural requirements of the dihydropyridine receptor alpha1S II-III loop for skeletal-type excitation-contraction coupling. J. Biol. Chem. 2004, 279:4721-4728.
50. Kuo A., Gulbis J.M., Antcliff J.F., Rahman T., Lowe E.D., Zimmer J., Cuthbertson J., Ashcroft F.M., Ezaki T., Doyle D.A. Crystal structure of the potassium channel KirBac1.1 in the closed state. Science 2003, 300:1922-1926.
51. 2+ entry into mouse skeletal muscle fibres. J. Physiol. 2001, 533:185-199.
52. Ledbetter M.W., Preiner J.K., Louis C.F., Mickelson J.R. Tissue distribution of ryanodine receptor isoforms and alleles determined by reverse transcription polymerase chain reaction. J. Biol. Chem. 1994, 269:31544-31551.
53. Lee E.H., Cherednichenko G., Pessah I.N., Allen P.D. Functional coupling between TRPC3 and RyR1 regulates the expressions of key triadic proteins. J. Biol. Chem. 2006, 281:10042-10048.
54. Lehnart S.E., Wehrens X.H., Marks A.R. Calstabin deficiency, ryanodine receptors, and sudden cardiac death. Biochem. Biophys. Res. Commun. 2004, 322:1267-1279.
55. Leong P., MacLennan D.H. The cytoplasmic loops between domains II and III and domains III and IV in the skeletal muscle dihydropyridine receptor bind to a contiguous site in the skeletal muscle ryanodine receptor. J. Biol. Chem. 1998, 273:29958-29964.
56. Louis M., Zanou N., Van Schoor M., Gailly P. TRPC1 regulates skeletal myoblast migration and differentiation. J. Cell Sci. 2008, 121:3951-3959.
57. 2+ entry in skeletal muscle on STIM1 and Orai1. J. Physiol. 2008, 586:4815-4824.
58. Lytton J., Westlin M., Burk S.E., Shull G.E., MacLennan D.H. Functional comparisons between isoforms of the sarcoplasmic or endoplasmic reticulum family of calcium pumps. J. Biol. Chem. 1992, 267:14483-14489.
59. MacLennan D.H., Phillips M.S. The role of the skeletal muscle ryanodine receptor (RYR1) gene in malignant hyperthermia and central core disease. Soc. Gen. Physiol. Ser. 1995, 50:89-100.
60. 2+ signalling and muscle disease. Eur. J. Biochem. 2000, 267:5291-5297.
61. Maruyama Y., Ogura T., Mio K., Kato K., Kaneko T., Kiyonaka S., Mori Y., Sato C. Tetrameric Orai1 is a teardrop-shaped molecule with a long, tapered cytoplasmic domain. J. Biol. Chem. 2009, 284:13676-13685.
62. Matthews, E., Hanna, M.G., 2010. Muscle channelopathies: does the predicted channel gating pore offer new treatment options for hypokalaemic periodic paralysis? J. Physiol. [Epub ahead of print].
63. Matthews E., Labrum R., Sweeney M.G., Sud R., Haworth A., Chinnery P.F., Meola G., Schorge S., Kullmann D.M., Davis M.B., Hanna M.G. Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology 2009, 72:1544-1547.
64. Millay D.P., Goonasekera S.A., Sargent M.A., Maillet M., Aronow B.J., Molkentin J.D. Calcium influx is sufficient to induce muscular dystrophy through a TRPC-dependent mechanism. Proc. Natl. Acad. Sci. U S A 2009, 106:19023-19028.
65. Mio K., Ogura T., Kiyonaka S., Hiroaki Y., Tanimura Y., Fujiyoshi Y., Mori Y., Sato C. The TRPC3 channel has a large internal chamber surrounded by signal sensing antennas. J. Mol. Biol. 2007, 367:373-383.
66. 2+ homeostasis and disease. Cell Calcium 2000, 28:1-21.
67. Monnier N., Procaccio V., Stieglitz P., Lunardi J. Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle. Am. J. Hum. Genet. 1997, 60:1316-1325.
68. Morrill J.A., Brown R.H., Cannon S.C. Gating of the L-type Ca channel in human skeletal myotubes: an activation defect caused by the hypokalemic periodic paralysis mutation R528H. J. Neurosci. 1998, 18:10320-10334.
69. Mygland A., Tysnes O.B., Aarli J.A., Flood P.R., Gilhus N.E. Myasthenia gravis patients with a thymoma have antibodies against a high molecular weight protein in sarcoplasmic reticulum. J. Neuroimmunol 1992, 37:1-7.
70. Mygland A., Tysnes O.B., Aarli J.A., Matre R., Gilhus N.E. IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma. J. Autoimmun. 1993, 6:507-515.
71. Mygland A., Aarli J.A., Matre R., Gilhus N.E. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis. J. Neurol. Neurosurg. Psychiatry 1994, 57:843-846.
72. Nagaraj R.Y., Nosek C.M., Brotto M.A., Nishi M., Takeshima H., Nosek T.M., Ma J. Increased susceptibility to fatigue of slow- and fast-twitch muscles from mice lacking the MG29 gene. Physiol. Genomics 2000, 4:43-49.
73. Nakai J., Dirksen R.T., Nguyen H.T., Pessah I.N., Beam K.G., Allen P.D. Enhanced dihydropyridine receptor channel activity in the presence of ryanodine receptor. Nature 1996, 380:72-75.
74. Nakai J., Tanabe T., Konno T., Adams B., Beam K.G. Localization in the II-III loop of the dihydropyridine receptor of a sequence critical for excitation-contraction coupling. J. Biol. Chem. 1998, 273:24983-24986.
75. Nilius B., Voets T. TRP channels: a TR(I)P through a world of multifunctional cation channels. Pflugers Arch. 2005, 451:1-10.
76. Nilius B., Owsianik G., Voets T., Peters J.A. Transient receptor potential cation channels in disease. Physiol. Rev. 2007, 87:165-217.
77. Nilius B., Owsianik G., Voets T. Transient receptor potential channels meet phosphoinositides. EMBO J. 2008, 27:2809-2816.
78. Nishi M., Mizushima A., Nakagawara K., Takeshima H. Characterization of human junctophilin subtype genes. Biochem. Biophys. Res. Commun. 2000, 273:920-927.
79. 2+-ATPase. J. Biol. Chem. 1998, 273:12360-12369.
80. 2+ ATPase (SERCA1) and is associated with Brody disease. Hum. Genet. 2000, 106:482-491.
81. Pan Z., Yang D., Nagaraj R.Y., Nosek T.A., Nishi M., Takeshima H., Cheng H., Ma J. Dysfunction of store-operated calcium channel in muscle cells lacking mg29. Nat. Cell Biol. 2002, 4:379-383.
82. Paolini C., Protasi F., Franzini-Armstrong C. The relative position of RyR feet and DHPR tetrads in skeletal muscle. J. Mol. Biol. 2004, 342:145-153.
83. 2+ entry: dynamic interplay between endoplasmic reticulum, mitochondria and plasma membrane. J. Physiol. 2003, 547:333-348.
84. Phillips M.S., Khanna V.K., De Leon S., Frodis W., Britt B.A., MacLennan D.H. The substitution of Arg for Gly2433 in the human skeletal muscle ryanodine receptor is associated with malignant hyperthermia. Hum. Mol. Genet. 1994, 3:2181-2186.
85. 2+ release channels. J. Clin. Invest. 2005, 115:2033-2038.
86. Proenza C., Wilkens C.M., Beam K.G. Excitation-contraction coupling is not affected by scrambled sequence in residues 681-690 of the dihydropyridine receptor II-III loop. J. Biol. Chem. 2000, 275:29935-29937.
87. Protasi F., Franzini-Armstrong C., Flucher B.E. Coordinated incorporation of skeletal muscle dihydropyridine receptors and ryanodine receptors in peripheral couplings of BC3H1 cells. J. Cell Biol. 1997, 137:859-870.
88. Protasi F., Takekura H., Wang Y., Chen S.R., Meissner G., Allen P.D., Franzini-Armstrong C. RYR1 and RYR3 have different roles in the assembly of calcium release units of skeletal muscle. Biophys. J. 2000, 79:2494-2508.
89. Quane K.A., Healy J.M., Keating K.E., Manning B.M., Couch F.J., Palmucci L.M., Doriguzzi C., Fagerlund T.H., Berg K., Ording H., et al. Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nat. Genet. 1993, 5:51-55.
90. Quane K.A., Keating K.E., Healy J.M., Manning B.M., Krivosic-Horber R., Krivosic I., Monnier N., Lunardi J., McCarthy T.V. Mutation screening of the RYR1 gene in malignant hyperthermia: detection of a novel Tyr to Ser mutation in a pedigree with associated central cores. Genomics 1994, 23:236-239.
91. Quane K.A., Keating K.E., Manning B.M., Healy J.M., Monsieurs K., Heffron J.J., Lehane M., Heytens L., Krivosic-Horber R., Adnet P., et al. Detection of a novel common mutation in the ryanodine receptor gene in malignant hyperthermia: implications for diagnosis and heterogeneity studies. Hum. Mol. Genet. 1994, 3:471-476.
92. Rios E., Pizarro G. Voltage sensor of excitation-contraction coupling in skeletal muscle. Physiol. Rev. 1991, 71:849-908.
93. Rosenberg P., Hawkins A., Stiber J., Shelton J.M., Hutcheson K., Bassel-Duby R., Shin D.M., Yan Z., Williams R.S. TRPC3 channels confer cellular memory of recent neuromuscular activity. Proc. Natl. Acad. Sci. USA 2004, 101:9387-9392.
94. Rossi A.E., Dirksen R.T. Sarcoplasmic reticulum: the dynamic calcium governor of muscle. Muscle Nerve 2006, 33:715-731.
95. 2+-release channels. Cell Calcium 2002, 32:307-319.
96. Rudel R., Lehmann-Horn F., Ricker K., Kuther G. Hypokalemic periodic paralysis: in vitro investigation of muscle fiber membrane parameters. Muscle Nerve 1984, 7:110-120.
97. Sabourin J., Lamiche C., Vandebrouck A., Magaud C., Rivet J., Cognard C., Bourmeyster N., Constantin B. Regulation of TRPC1 and TRPC4 cation channels requires an alpha1-syntrophin-dependent complex in skeletal mouse myotubes. J. Biol. Chem. 2009, 284:36248-36261.
98. Sagnella G.A., Markandu N.D., Singer D.R., Buckley M.G., Miller M.A., MacGregor G.A. Humoral effects of perindopril in essential hypertension. Eur. J. Clin. Pharmacol. 1991, 41:625-626.
99. Saiki Y., El-Hayek R., Ikemoto N. Involvement of the Glu724-Pro760 region of the dihydropyridine receptor II-III loop in skeletal muscle-type excitation-contraction coupling. J. Biol. Chem. 1999, 274:7825-7832.
100. Sampieri A., Diaz-Munoz M., Antaramian A., Vaca L. The foot structure from the type 1 ryanodine receptor is required for functional coupling to store-operated channels. J. Biol. Chem. 2005, 280:24804-24815.
101. Samso M., Wagenknecht T. Contributions of electron microscopy and single-particle techniques to the determination of the ryanodine receptor three-dimensional structure. J. Struct. Biol. 1998, 121:172-180.
102. Samso M., Feng W., Pessah I.N., Allen P.D. Coordinated movement of cytoplasmic and transmembrane domains of RyR1 upon gating. PLoS Biol. 2009, 7:e85.
103. Santillan G., Baldi C., Katz S., Vazquez G., Boland R. Evidence that TRPC3 is a molecular component of the 1alpha,25(OH)2D3-activated capacitative calcium entry (CCE) in muscle and osteoblast cells. J. Steroid Biochem. Mol. Biol. 2004, 89-90:291-295.
104. Schredelseker J., Di Biase V., Obermair G.J., Felder E.T., Flucher B.E., Franzini-Armstrong C., Grabner M. The beta 1a subunit is essential for the assembly of dihydropyridine-receptor arrays in skeletal muscle. Proc. Natl. Acad. Sci. USA 2005, 102:17219-17224.
105. 2+ channel by electron cryomicroscopy. Proc. Natl. Acad. Sci. U S A 2002, 99:10370-10375.
106. Serysheva I.I., Ludtke S.J., Baker M.L., Cong Y., Topf M., Eramian D., Sali A., Hamilton S.L., Chiu W. Subnanometer-resolution electron cryomicroscopy-based domain models for the cytoplasmic region of skeletal muscle RyR channel. Proc. Natl. Acad. Sci. U S A 2008, 105:9610-9615.
107. Sheridan D.C., Takekura H., Franzini-Armstrong C., Beam K.G., Allen P.D., Perez C.F. Bidirectional signaling between calcium channels of skeletal muscle requires multiple direct and indirect interactions. Proc. Natl. Acad. Sci. USA 2006, 103:19760-19765.
108. 2+-release channels. Am. J. Physiol. 1997, 272:C1475-C1481.
109. Sokolov S., Scheuer T., Catterall W.A. Gating pore current in an inherited ion channelopathy. Nature 2007, 446:76-78.
110. Sokolov S., Scheuer T., Catterall W.A. Depolarization-activated gating pore current conducted by mutant sodium channels in potassium-sensitive normokalemic periodic paralysis. Proc. Natl. Acad. Sci. U S A 2008, 105:19980-19985.
111. Stiber J., Hawkins A., Zhang Z.S., Wang S., Burch J., Graham V., Ward C.C., Seth M., Finch E., Malouf N., Williams R.S., Eu J.P., Rosenberg P. STIM1 signalling controls store-operated calcium entry required for development and contractile function in skeletal muscle. Nat. Cell Biol. 2008, 10:688-697.
112. 2+ transients in skeletal muscle deficient in dihydropyridine receptor beta 1 subunit. Biophys. J. 1996, 71:2531-2543.
113. + channel mutation linked to hypokalemic periodic paralysis exposes a proton-selective gating pore. J. Gen. Physiol. 2007, 130:11-20.
114. Struyk A.F., Markin V.S., Francis D., Cannon S.C. Gating pore currents in DIIS4 mutations of NaV1.4 associated with periodic paralysis: saturation of ion flux and implications for disease pathogenesis. J. Gen. Physiol. 2008, 132:447-464.
115. Takamori M. Autoantibodies against TRPC3 and ryanodine receptor in myasthenia gravis. J. Neuroimmunol 2008, 200:142-144.
116. Takeshima H., Nishimura S., Matsumoto T., Ishida H., Kangawa K., Minamino N., Matsuo H., Ueda M., Hanaoka M., Hirose T., et al. Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature 1989, 339:439-445.
117. Takeshima H., Shimuta M., Komazaki S., Ohmi K., Nishi M., Iino M., Miyata A., Kangawa K. Mitsugumin29, a novel synaptophysin family member from the triad junction in skeletal muscle. Biochem. J. 1998, 331(Pt 1):317-322.
118. Takeshima H., Komazaki S., Nishi M., Iino M., Kangawa K. Junctophilins: a novel family of junctional membrane complex proteins. Mol. Cell 2000, 6:11-22.
119. Tanabe T., Beam K.G., Powell J.A., Numa S. Restoration of excitation-contraction coupling and slow calcium current in dysgenic muscle by dihydropyridine receptor complementary DNA. Nature 1988, 336:134-139.
120. Tanabe T., Beam K.G., Adams B.A., Niidome T., Numa S. Regions of the skeletal muscle dihydropyridine receptor critical for excitation-contraction coupling. Nature 1990, 346:567-569.
121. Treves S., Anderson A.A., Ducreux S., Divet A., Bleunven C., Grasso C., Paesante S., Zorzato F. Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders. Neuromuscul Disord. 2005, 15:577-587.
122. Treves S., Jungbluth H., Muntoni F., Zorzato F. Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm. Curr. Opin. Pharmacol. 2008, 8:319-326.
123. Vandebrouck C., Martin D., Colson-Van Schoor M., Debaix H., Gailly P. Involvement of TRPC in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers. J. Cell Biol. 2002, 158:1089-1096.
124. Venkatachalam K., Montell C. TRP channels. Annu. Rev. Biochem. 2007, 76:387-417.
125. Wagenknecht T., Samso M. Three-dimensional reconstruction of ryanodine receptors. Front. Biosci. 2002, 7:d1464-d1474.
126. Wang M.C., Velarde G., Ford R.C., Berrow N.S., Dolphin A.C., Kitmitto A. 3D structure of the skeletal muscle dihydropyridine receptor. J. Mol. Biol. 2002, 323:85-98.
127. Wang Q., Liu M., Xu C., Tang Z., Liao Y., Du R., Li W., Wu X., Wang X., Liu P., Zhang X., Zhu J., Ren X., Ke T., Yang J. Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a Chinese family. J. Mol. Med. 2005, 83:203-208.
128. 2+ release event activity in both intact and permeabilized myotubes. Biophys. J. 2001, 81:3216-3230.
129. 2+ sparks as a plastic signal for skeletal muscle health, aging, and dystrophy. Acta Pharmacol. Sin 2006, 27:791-798.
130. 2+ release. J. Cell Biol. 2006, 174:639-645.
131. Weiss R.G., O'Connell K.M., Flucher B.E., Allen P.D., Grabner M., Dirksen R.T. Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling. Am. J. Physiol. Cell Physiol. 2004, 287:C1094-C1102.
132. Wilkins B.J., Molkentin J.D. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem. Biophys. Res. Commun. 2004, 322:1178-1191.
133. 2+ channel using electron cryo-microscopy. J. Mol. Biol. 2003, 332:171-182.
134. Woo J.S., Kim D.H., Allen P.D., Lee E.H. TRPC3-interacting triadic proteins in skeletal muscle. Biochem. J. 2008, 411:399-405.
135. Woo J.S., Hwang J.H., Ko J.K., Kim D.H., Ma J., Lee E.H. Glutamate at position 227 of junctophilin-2 is involved in binding to TRPC3. Mol. Cell Biochem. 2009.
136. Wu S., Ibarra M.C., Malicdan M.C., Murayama K., Ichihara Y., Kikuchi H., Nonaka I., Noguchi S., Hayashi Y.K., Nishino I. Central core disease is due to RYR1 mutations in more than 90% of patients. Brain 2006, 129:1470-1480.
137. Yang T., Allen P.D., Pessah I.N., Lopez J.R. Enhanced excitation-coupled calcium entry in myotubes is associated with expression of RyR1 malignant hyperthermia mutations. J. Biol. Chem. 2007, 282:37471-37478.
138. Yeromin A.V., Zhang S.L., Jiang W., Yu Y., Safrina O., Cahalan M.D. Molecular identification of the CRAC channel by altered ion selectivity in a mutant of Orai. Nature 2006, 443:226-229.
139. 2+ store functions in skeletal and cardiac muscle cells from sarcalumenin-deficient mice. J. Biol. Chem. 2005, 280:3500-3506.
140. Yu Y., Fantozzi I., Remillard C.V., Landsberg J.W., Kunichika N., Platoshyn O., Tigno D.D., Thistlethwaite P.A., Rubin L.J., Yuan J.X. Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension. Proc. Natl. Acad. Sci. U S A 2004, 101:13861-13866.
141. Zalk R., Lehnart S.E., Marks A.R. Modulation of the ryanodine receptor and intracellular calcium. Annu. Rev. Biochem. 2007, 76:367-385.
142. Zhou H., Yamaguchi N., Xu L., Wang Y., Sewry C., Jungbluth H., Zorzato F., Bertini E., Muntoni F., Meissner G., Treves S. Characterization of recessive RYR1 mutations in core myopathies. Hum. Mol. Genet. 2006, 15:2791-2803.
143. 2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum. J. Biol. Chem. 1990, 265:2244-2256.
144. Zorzato F., Anderson A.A., Ohlendieck K., Froemming G., Guerrini R., Treves S. Identification of a novel 45 kDa protein (JP-45) from rabbit sarcoplasmic-reticulum junctional-face membrane. Biochem. J. 2000, 351(Pt 2):537-543.
145. 2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states. Pharmacol. Rev. 1997, 49:1-51.